Alaattin SEN

Prof. Dr. Alaattin SEN

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2020 in World Journal of Clinical Cases
Verified
Journal Article
Open access
ASAlaattin SEN
Alaattin SEN
Oleanolic acid (OA) and its derivatives are widely found in diverse plants and are naturally effective pentacyclic triterpenoid compounds with broad prophylactic and therapeutic roles in various diseases such as ulcerative colitis, multiple sclerosis, metabolic disorders, diabetes, hepatitis and different cancers. This review assembles and presents the latest in vivo reports on the impacts of OA and OA derivatives from various plant sources and the biological mechanisms of OA activities. Thus, this review presents sufficient data proposing that OA and its derivatives are potential alternative and complementary therapies for the treatment and management of several diseases.

1 January 2000 in Pure and Applied Chemistry
Verified
Journal Article
Closed access
EAEmel Arinç
Emel Arinç
ASAlaattin SEN
Alaattin SEN
ABAzra Bozcaarmutlu
Azra Bozcaarmutlu
Polycyclic aromatic hydrocarbons (PAHs), dioxins, dibenzofurans, and polychlorinated biphenyls (PCBs) present in polluted environment induce cytochrome P4501A (CYP1A) isozyme in fish, which in turn results in a marked increased production of carcinogenic metabolites from PAHs. The induction of hepatic CYP1A in fish by certain classes of chemicals has been suggested as an early warning system, a "most sensitive biological response" for assessing environmental contamination conditions. This has implications for human fish consumption, as well as for the health status of aquatic organisms. Correlation between elevated CYP1A and altered steroid metabolism and decreased reproductive success has been pointed out. The induction of CYP1A and associated enzyme activities has now been confirmed in a number of field studies. Cases where these biomarkers have been studied in field conditions will be presented. Special emphasis will be given to field studies in which the induction of CYP1A activity, 7-ethoxyresorufin O-deethylase (EROD) activities and immunochemical detection of CYP1A in leaping mullet and common sole are used as a biomarker for PAH- and/or PCB-type pollutants along the Izmir Bay on the Aegean Sea.

1 November 2007 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
ASAlaattin SEN
Alaattin SEN
ASAsli Semiz
Asli Semiz

1 September 2004 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
ASAlaattin SEN
Alaattin SEN
AKA. Kirikbakan
A. Kirikbakan

1 January 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GCGurbet Celik
Gurbet Celik
ASAslı Semiz
Aslı Semiz
SKSerdar Karakurt
Serdar Karakurt
SASevki Arslan
Sevki Arslan
OAOrhan Adali
Orhan Adali
ASAlaattin SEN
Alaattin SEN
The present study was designed to evaluate different doses of ellagic acid (EA)in vivoin rats for its potential to modulate hepatic phases I, II, and antioxidant enzymes. EA (10 or 30 mg/kg/day, intragastrically) was administered for 14 consecutive days, and activity, protein, and mRNA levels were determined. Although the cytochrome P450 (CYP) 2B and CYP2E enzyme activities were decreased significantly, the activities of all other enzymes were unchanged with the 10 mg/kg/day EA. In addition, western-blot and qRT-PCR results clearly corroborated the above enzyme expressions. On the other hand, while the NAD(P)H:quinone oxidoreductase 1 (NQO1), catalase (CAT), glutathione peroxidase (GPX), and glutathione S-transferase (GST) activities were increased significantly, CYP1A, 2B, 2C, 2E, and 19 enzyme activities were reduced significantly with 30 mg/kg/day EA. In addition, CYP2B, 2C6, 2E1, and 19 protein and mRNA levels were substantially decreased by the 30 mg/kg/day dose of EA, but the CYP1A protein, and mRNA levels were not changed. CYP3A enzyme activity, protein and mRNA levels were not altered by neither 10 nor 30 mg/kg/day ellagic acid. These results indicate that EA exerts a dose-dependent impact on the metabolism of chemical carcinogens and drugs by affecting the enzymes involved in xenobiotics activation/detoxification and antioxidant pathways.

1 December 2001 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
SLSu- Jun Leea
Su- Jun Leea
OHOlaf R. Hedstrom
Olaf R. Hedstrom
KFKay Fischerc
Kay Fischerc
JWJun-Lan Wang-Buhler
Jun-Lan Wang-Buhler
ASAlaattin SEN
Alaattin SEN
DBDonald R. Buhler
Donald R. Buhler